-
Je něco špatně v tomto záznamu ?
Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study
S. Strebel, K. Baust, D. Grabow, J. Byrne, T. Langer, A. Am Zehnhoff-Dinnesen, R. Kuonen, A. Weiss, T. Kepak, J. Kruseova, C. Berger, G. Calaminus, G. Sommer, CE. Kuehni, PanCareLIFE Consortium
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
602030
European Union's Seventh Framework Program
KLS-3412-02-2014
Krebsliga Schweiz
KFS-4157-02-2017
Swiss Cancer Research Foundation
110298
German Cancer Aid
7E13061
University Hospital of Brno from the Ministry of Education, Youth and Sports of the Czech Republic
- MeSH
- dítě MeSH
- dospělí MeSH
- kohortové studie MeSH
- kvalita života * MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- nádory * komplikace psychologie MeSH
- nedoslýchavost * epidemiologie etiologie MeSH
- předškolní dítě MeSH
- prevalence MeSH
- přežívající onkologičtí pacienti * psychologie MeSH
- průzkumy a dotazníky MeSH
- tinnitus * etiologie epidemiologie MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
PURPOSE: Auditory complications are potential side effects from childhood cancer treatment. Yet, limited evidence exists about the impact of auditory complications-particularly tinnitus-on health-related quality of life (HRQoL) among childhood cancer survivors (CCS). We determined the prevalence of hearing loss and tinnitus in the European PanCareLIFE cohort of CCS and examined its effect on HRQoL. METHODS: We included CCS from four European countries who were diagnosed at age ≤ 18 years; survived ≥ 5 years; and aged 25-44 years at study. We assessed HRQoL (Short Form 36), hearing loss, and tinnitus using questionnaires. We used multivariable linear regression to examine associations between these two auditory complications and HRQoL adjusting for socio-demographic and clinical factors. RESULTS: Our study population consisted of 6,318 CCS (53% female; median age at cancer diagnosis 9 years interquartile range [IQR] 5-13 years) with median age at survey of 31 years (IQR 28-35 years). Prevalence was 7.5% (476/6,318; confidence interval [CI]: 6.9-8.2) for hearing loss and 7.6% (127/1,668; CI: 6.4-9.0) for tinnitus. CCS with hearing loss had impaired physical (coefficient [coef.] -4.3, CI: -7.0 to -1.6) and mental (coef. -3.2, CI: -5.5 to -0.8) HRQoL when compared with CCS with normal hearing. Tinnitus was associated with impaired physical (coef. -8.2, CI: -11.8 to -4.7) and mental (coef. -5.9, CI: -8.8 to -3.1) HRQoL. CONCLUSION: We observed reduced HRQoL among CCS with hearing loss and tinnitus. Our findings indicate timely treatment of hearing loss and tinnitus may contribute to quality of life of survivors. IMPLICATIONS FOR CANCER SURVIVORS: CCS who experience auditory complications should be counseled about possible therapeutic and supportive measures during follow-up care.
Bavarian Care and Nursing Authority Amberg Germany
Boyne Research Institute Drogheda Ireland
Department of BioMedical Research University of Bern Bern Switzerland
Department of Pediatric Hematology and Oncology University Hospital Bonn Bonn Germany
Department of Pediatric Hematology and Oncology University Hospital Saint Étienne France
Department of Pediatrics Inselspital Bern University Hospital University of Bern Bern Switzerland
Graduate School for Health Sciences University of Bern Bern Switzerland
Lyon University Jean Monnet University INSERM U 1059 Sainbiose Saint Étienne France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010152
- 003
- CZ-PrNML
- 005
- 20250429135539.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11764-023-01456-4 $2 doi
- 035 __
- $a (PubMed)37736773
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Strebel, Sven $u Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland $u CANSEARCH Research Platform in Pediatric Oncology and Hematology, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland $u Graduate School for Health Sciences, University of Bern, Bern, Switzerland
- 245 10
- $a Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study / $c S. Strebel, K. Baust, D. Grabow, J. Byrne, T. Langer, A. Am Zehnhoff-Dinnesen, R. Kuonen, A. Weiss, T. Kepak, J. Kruseova, C. Berger, G. Calaminus, G. Sommer, CE. Kuehni, PanCareLIFE Consortium
- 520 9_
- $a PURPOSE: Auditory complications are potential side effects from childhood cancer treatment. Yet, limited evidence exists about the impact of auditory complications-particularly tinnitus-on health-related quality of life (HRQoL) among childhood cancer survivors (CCS). We determined the prevalence of hearing loss and tinnitus in the European PanCareLIFE cohort of CCS and examined its effect on HRQoL. METHODS: We included CCS from four European countries who were diagnosed at age ≤ 18 years; survived ≥ 5 years; and aged 25-44 years at study. We assessed HRQoL (Short Form 36), hearing loss, and tinnitus using questionnaires. We used multivariable linear regression to examine associations between these two auditory complications and HRQoL adjusting for socio-demographic and clinical factors. RESULTS: Our study population consisted of 6,318 CCS (53% female; median age at cancer diagnosis 9 years interquartile range [IQR] 5-13 years) with median age at survey of 31 years (IQR 28-35 years). Prevalence was 7.5% (476/6,318; confidence interval [CI]: 6.9-8.2) for hearing loss and 7.6% (127/1,668; CI: 6.4-9.0) for tinnitus. CCS with hearing loss had impaired physical (coefficient [coef.] -4.3, CI: -7.0 to -1.6) and mental (coef. -3.2, CI: -5.5 to -0.8) HRQoL when compared with CCS with normal hearing. Tinnitus was associated with impaired physical (coef. -8.2, CI: -11.8 to -4.7) and mental (coef. -5.9, CI: -8.8 to -3.1) HRQoL. CONCLUSION: We observed reduced HRQoL among CCS with hearing loss and tinnitus. Our findings indicate timely treatment of hearing loss and tinnitus may contribute to quality of life of survivors. IMPLICATIONS FOR CANCER SURVIVORS: CCS who experience auditory complications should be counseled about possible therapeutic and supportive measures during follow-up care.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a kvalita života $7 D011788
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a přežívající onkologičtí pacienti $x psychologie $7 D000073116
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a tinnitus $x etiologie $x epidemiologie $7 D014012
- 650 12
- $a nedoslýchavost $x epidemiologie $x etiologie $7 D034381
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a mladiství $7 D000293
- 650 12
- $a nádory $x komplikace $x psychologie $7 D009369
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a kohortové studie $7 D015331
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Baust, Katja $u Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany
- 700 1_
- $a Grabow, Desiree $u Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
- 700 1_
- $a Byrne, Julianne $u Boyne Research Institute, Drogheda, Ireland
- 700 1_
- $a Langer, Thorsten $u Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany
- 700 1_
- $a Am Zehnhoff-Dinnesen, Antoinette $u Department for Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhems University, Münster, Germany
- 700 1_
- $a Kuonen, Rahel $u Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland $u Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- 700 1_
- $a Weiss, Annette $u Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland $u Bavarian Care and Nursing Authority, Amberg, Germany
- 700 1_
- $a Kepak, Tomas $u University Hospital Brno & International Clinical Research Center (FNUSA-ICRC), Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kruseova, Jarmila $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Berger, Claire $u Department of Pediatric Hematology and Oncology, University-Hospital, Saint-Étienne, France $u Lyon University, Jean Monnet University, INSERM U 1059, Sainbiose, Saint-Étienne, France
- 700 1_
- $a Calaminus, Gabriele $u Department of Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany
- 700 1_
- $a Sommer, Grit $u Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland $u Department of Pediatric Endocrinology, Diabetology and Metabolism, Inselspital, Bern University Children's Hospital, University of Bern, Bern, Switzerland $u Department of BioMedical Research, University of Bern, Bern, Switzerland
- 700 1_
- $a Kuehni, Claudia E $u Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland. claudia.kuehni@unibe.ch $u Division of Pediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. claudia.kuehni@unibe.ch
- 710 2_
- $a PanCareLIFE Consortium
- 773 0_
- $w MED00210173 $t Journal of cancer survivorship $x 1932-2267 $g Roč. 19, č. 1 (2025), s. 162-173
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37736773 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135534 $b ABA008
- 999 __
- $a ok $b bmc $g 2311500 $s 1247233
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 19 $c 1 $d 162-173 $e 20230922 $i 1932-2267 $m Journal of cancer survivorship $n J Cancer Surviv $x MED00210173
- GRA __
- $a 602030 $p European Union's Seventh Framework Program
- GRA __
- $a KLS-3412-02-2014 $p Krebsliga Schweiz
- GRA __
- $a KFS-4157-02-2017 $p Swiss Cancer Research Foundation
- GRA __
- $a 110298 $p German Cancer Aid
- GRA __
- $a 7E13061 $p University Hospital of Brno from the Ministry of Education, Youth and Sports of the Czech Republic
- LZP __
- $a Pubmed-20250415